Canada markets closed

Ampio Pharmaceuticals, Inc. (APH0.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.18100.0000 (0.00%)
At close: 08:11AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
2,439
2,439
8,916
11,900
9,172
Selling General and Administrative
7,079
7,079
11,466
8,671
6,650
Total Operating Expenses
9,518
9,518
20,382
20,571
15,834
Operating Income or Loss
-9,518
-9,518
-20,382
-20,571
-15,834
Total Other Income/Expenses Net
538
538
3,825
3,492
-72
Income Before Tax
-8,632
-8,632
-16,337
-17,075
-15,894
Income from Continuing Operations
-8,632
-8,632
-16,337
-17,075
-15,894
Net Income
-8,632
-8,632
-16,337
-17,075
-15,894
Net Income available to common shareholders
-8,632
-8,632
-16,337
-17,075
-15,894
Basic EPS
-11.05
-10.66
-21.68
-27.00
-27.00
Diluted EPS
-11.70
-10.66
-29.32
-30.00
-27.00
Basic Average Shares
791.522
810.113
753.615
664.33
576.155
Diluted Average Shares
791.522
810.113
753.615
683.21
576.155